Bone marrow transplantation has found during the last decade his major indications which are severe aplastic anemia and acute leukemia in complete remission. For the time being, bone marrow transplant is feasible only if the patient has an HLA identical sibling. Efforts are being made to improve the prognosis of complications such as graft versus host disease and interstitial pneumonitis. The long term survival currently obtained is over 50 per cent.